Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis

BACKGROUND/AIMS: Therapies involving bone-marrow-derived mesenchymal stem cells (BM-MSCs) have considerable potential in the management of hepatic disease. BM-MSCs have been investigated in regenerative medicine due to their ability to secrete various growth factors and cytokines that regress hepati...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Yoon Ok, Jun, Baek Gyu, Baik, Soon Koo, Kim, Moon Young, Kwon, Sang Ok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493357/
https://www.ncbi.nlm.nih.gov/pubmed/26157751
http://dx.doi.org/10.3350/cmh.2015.21.2.141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493357/
https://www.ncbi.nlm.nih.gov/pubmed/26157751
http://dx.doi.org/10.3350/cmh.2015.21.2.141

Ejemplares similares